Tadalafil biomo 5mg film-coated tablets Malta - English - Medicines Authority

tadalafil biomo 5mg film-coated tablets

biomo pharma gmbh josef-dietzgen-straße 3, d-53773, hennef,, germany - tadalafil - film-coated tablet - tadalafil 5 mg - urologicals

Tadalafil Welding 5mg film-coated tablets Malta - English - Medicines Authority

tadalafil welding 5mg film-coated tablets

welding gmbh & co. kg esplanade 39, 20354, hamburg, germany - tadalafil - film-coated tablet - tadalafil 5 milligram(s) - urologicals

Tadalafil Welding 10mg film-coated tablets Malta - English - Medicines Authority

tadalafil welding 10mg film-coated tablets

welding gmbh & co. kg esplanade 39, 20354, hamburg, germany - tadalafil - film-coated tablet - tadalafil 10 milligram(s) - urologicals

Tadalafil Welding 20mg film-coated tablets Malta - English - Medicines Authority

tadalafil welding 20mg film-coated tablets

welding gmbh & co. kg esplanade 39, 20354, hamburg, germany - tadalafil - film-coated tablet - tadalafil 20 milligram(s) - urologicals

Tadalafil Aristo PAH 20mg film-coated Tablets Malta - English - Medicines Authority

tadalafil aristo pah 20mg film-coated tablets

aristo pharma gmbh wallenroder straße 8–10, 13435, berlin, germany - tadalafil - film-coated tablet - tadalafil 20 mg - urologicals

Filgrastim ratiopharm European Union - English - EMA (European Medicines Agency)

filgrastim ratiopharm

ratiopharm gmbh - filgrastim - neutropenia; hematopoietic stem cell transplantation; cancer - immunostimulants, - filgrastim ratiopharm is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia. the safety and efficacy of filgrastim are similar in adults and children receiving cytotoxic chemotherapy.filgrastim ratiopharm is indicated for the mobilisation of peripheral blood progenitor cells (pbpc).in patients, children or adults, with severe congenital, cyclic, or idiopathic neutropenia with an absolute neutrophil count (anc) of 0.5 x 109/l, and a history of severe or recurrent infections, long term administration of filgrastim ratiopharm is indicated to increase neutrophil counts and to reduce the incidence and duration of infection-related events.filgrastim ratiopharm is indicated for the treatment of persistent neutropenia (anc less than or equal to 1.0 x 109/l) in patients with advanced hiv infection, in order to reduce the risk of bacterial infections when other options to manage neutropenia are inappropriate.

Removab European Union - English - EMA (European Medicines Agency)

removab

neovii biotech gmbh - catumaxomab - ascites; cancer - other antineoplastic agents - removab is indicated for the intraperitoneal treatment of malignant ascites in patients with epcam-positive carcinomas where standard therapy is not available or no longer feasible.,

Ramipril TAD 1.25 mg tablets Malta - English - Medicines Authority

ramipril tad 1.25 mg tablets

tad pharma gmbh heinz-lohmann-strasse 5, 27472 cuxhaven, germany - ramipril - tablet - ramipril 1.25 mg - agents acting on the renin-angiotensin system

Ramipril TAD 2.5 mg tablets Malta - English - Medicines Authority

ramipril tad 2.5 mg tablets

tad pharma gmbh heinz-lohmann-strasse 5, 27472 cuxhaven, germany - ramipril - tablet - ramipril 2.5 mg - agents acting on the renin-angiotensin system

Ramipril TAD 5 mg tablets Malta - English - Medicines Authority

ramipril tad 5 mg tablets

tad pharma gmbh heinz-lohmann-strasse 5, 27472 cuxhaven, germany - ramipril - tablet - ramipril 5 mg - agents acting on the renin-angiotensin system